Analysis of the catecholaminergic phenotype in human SH-SY5Y and BE(2)-M17 neuroblastoma cell lines upon differentiation

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Filograna, Roberta ^a   Civiero, Laura ^a   Ferrari, Vanni ^a   Codolo, Gaia ^a   Greggio, Elisa ^a   Bubacco, Luigi ^a   Beltramini, Mariano ^a   Bisaglia, Marco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; BETA TUBULIN; BETA TUBULIN III; CATECHOLAMINE; CHOLINE ACETYLTRANSFERASE; DOPAMINE; GLUTAMATE DECARBOXYLASE; NEUROFILAMENT PROTEIN; NORADRENALIN; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; STAUROSPORINE; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER;

ARTICLE; CATECHOLAMINE SYNTHESIS; CELL STRUCTURE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROBLASTOMA CELL LINE; BIOSYNTHESIS; CELL DIFFERENTIATION; DRUG EFFECTS; METABOLISM; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

CATECHOLAMINES; CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; NEUROBLASTOMA; STAUROSPORINE; TETRADECANOYLPHORBOL ACETATE; TRETINOIN;

EID: 84943311552     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136769     Document Type: Article

References (34)

1. Chinta SJ, Andersen JK. Dopaminergic neurons. Int J BiochemCell Biol. 2005;37(5):942-6. Epub 2005/03/04. doi: 10.1016/j.biocel.2004.09.009 PMID: 15743669.
2. Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev. 2003;42(1):33-84. Epub 2003/04/02. doi: 10.1016/S0165-0173 (03) 00143-7 PMID: 12668290.
3. Grimm J, Mueller A, Hefti F, Rosenthal A. Molecular basis for catecholaminergic neuron diversity. Proc Natl Acad Sci USA. 2004;101(38):13891-6. Epub 2004/09/09. doi: 10.1073/pnas.0405340101 PMID: 15353588; PubMed Central PMCID: PMC518849.
4. Radio NM, Mundy WR. Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology. 2008;29(3):361-76. Epub 2008/04/12. doi: 10.1016/j. neuro.2008.02.011 PMID: 18403021.
5. Zhao H, Li L, Fan HJ, Wang F, Jiang LM, He PG, et al. Exocytosis of SH-SY5Y single cell with different shapes cultured on ITO micro-pore electrode. MolCell Biochem. 2012;363(1-2):309-13. Epub 2011/12/06. doi: 10.1007/s11010-011-1183-9 PMID: 22139348.
6. Shi BX, Wang Y, Lam TL, Huang WH, Zhang K, Leung YC, et al. Release monitoring of single cells on a microfluidic device coupled with fluorescence microscopy and electrochemistry. Biomicrofluidics. 2010;4(4):43009. Epub 2011/01/27. doi: 10.1063/1.3491470 PMID: 21267086; PubMed Central PMCID: PMC3026031.
7. Andres D, Keyser BM, Petrali J, Benton B, Hubbard KS, McNutt PM, et al. Morphological and functional differentiation in BE (2)-M17human neuroblastoma cells by treatment with Trans-retinoic acid. BMC Neurosci. 2013;14:49. Epub 2013/04/20. doi: 10.1186/1471-2202-14-49 PMID: 23597229; PubMed Central PMCID: PMC3639069.
8. Daniele F, Di Cairano ES, Moretti S, Piccoli G, Perego C. TIRFM and pH-sensitive GFP-probes to Evaluate Neurotransmitter Vesicle Dynamics in SH-SY5Y Neuroblastoma Cells: Cell Imaging and Data Analysis. J Vis Exp. 2015;95:e52267. doi: 10.3791/52267
9. Webster NJ, Vaughan PF, Peers C. Hypoxic enhancement of evoked noradrenaline release from the human neuroblastoma SH-SY5Y. Brain Res Mol Brain Res. 2001;89(1-2):50-7. Epub 2001/04/20. doi: 10.1016/S0169-328X (01) 00061-4 PMID: 11311975.
10. Lopes FM, Schroder R, Da Frota ML Jr., Zanotto-Filho A, Muller CB, Pires AS, et al. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res. 2010;1337:85-94. Epub 2010/04/13. doi: 10.1016/j.brainres.2010.03.102 PMID: 20380819.
11. Xie HR, Hu LS, Li GY. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin Med J (Engl). 2010;123(8):1086-92. Epub 2010/05/26. PMID: 20497720.
12. Korecka JA, Van Kesteren RE, Blaas E, Spitzer SO, Kamstra JH, Smit AB, et al. Phenotypiccharacterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoSOne. 2013;8(5):e63862. Epub 2013/06/01. doi: 10.1371/journal.pone.0063862 PMID: 23724009; PubMed Central PMCID: PMC3665836.
13. Ross RA, Spengler BA, Biedler JL. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst. 1983;71(4):741-7. Epub 1983/10/01. PMID: 6137586.
14. Pahlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ. 1984;14(2):135-44. Epub 1984/06/01. PMID: 6467378.
15. Pahlman S, Odelstad L, Larsson E, Grotte G, Nilsson K. Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int J Cancer. 1981;28(5):583-9. Epub 1981/11/15. PMID: 7309295.
16. Pahlman S, Ruusala AI, Abrahamsson L, Odelstad L, Nilsson K. Kinetics and concentration effects of TPA-induced differentiation of cultured human neuroblastoma cells. Cell Differ. 1983;12(3):165-70. Epub 1983/03/01. PMID: 6299586.
17. Spinelli W, Sonnenfeld KH, Ishii DN. Effects of phorbol estertumor promoters and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells. Cancer Res. 1982;42(12):5067-73. Epub 1982/12/01. PMID: 7139611.
18. Kume T, Kawato Y, Osakada F, Izumi Y, Katsuki H, Nakagawa T, et al. Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype. Neurosci Lett. 2008;443(3):199-203. Epub 2008/08/12. doi: 10.1016/j.neulet.2008.07.079 PMID: 18691633.
19. Jalava A, Heikkila J, Lintunen M, Akerman K, Pahlman S. Staurosporine induces a neuronal phenotype in SH-SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12-O-tetradecanoyl phorbol-13 acetate (TPA). FEBS Lett. 1992;300(2):114-8. Epub 1992/03/30. doi: 10.1016/0014-5793 (92) 80176-H PMID: 1348695.
20. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 1989;49(1):219-25. Epub 1989/01/01. PMID: 2535691.
21. Rettig WJ, Spengler BA, Chesa PG, Old LJ, Biedler JL. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res. 1987;47(5):1383-9. Epub 1987/03/01. PMID: 3028608.
22. Melino G, Thiele CJ, Knight RA, Piacentini M. Retinoids and the control of growth/death decisions in human neuroblastoma cell lines. J Neurooncol. 1997;31(1-2):65-83. Epub 1997/01/01. PMID: 9049832.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods. 2001;25(4):402-8. Epub 2002/02/16. doi: 10.1006/meth.2001.1262 PMID: 11846609.
24. Datki Z, Juhasz A, Galfi M, Soos K, Papp R, Zadori D, et al. Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells. Brain Res Bull. 2003;62(3):223-9. Epub 2003/12/31. doi: 10.1016/j.brainresbull.2003.09.011 PMID: 14698355.
25. Clagett-Dame M, McNeill EM, Muley PD. Role of all-trans retinoic acid in neurite outgrowth andaxonal elongation. J Neurobiol. 2006;66(7):739-56. Epub 2006/05/12. doi: 10.1002/neu.20241 PMID: 16688769.
26. Uemura K, Kitagawa N, Kohno R, Kuzuya A, Kageyama T, Shibasaki H, et al. Presenilin 1 mediates retinoic acid-induced differentiation of SH-SY5Y cells through facilitation of Wnt signaling. J Neurosci Res. 2003;73(2):166-75. Epub 2003/07/02. doi: 10.1002/jnr.10641 PMID: 12836159.
27. Kim SN, Kim SG, Park SD, Cho-Chung YS, Hong SH. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells. J Cell Physiol. 2000;182(3):421-8. Epub 2000/02/01. doi: 10.1002/(SICI) 1097-4652 (200003) 182:3<421::AID-JCP13>3.0. CO;2-2 PMID: 10653609.
28. Fagerstrom S, Pahlman S, Gestblom C, Nanberg E. Protein kinase C-epsilon is implicated in neurite outgrowth in differentiating human neuroblastoma cells. Cell Growth Differ. 1996;7(6):775-85. Epub 1996/06/01. PMID: 8780891.
29. Jalava A, Akerman K, Heikkila J. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway. J Cell Physiol. 1993;155(2):301-12. Epub 1993/05/01. doi: 10.1002/jcp. 1041550211 PMID: 8482723.
30. Leli U, Cataldo A, Shea TB, Nixon RA, Hauser G. Distinct mechanisms of differentiation of SH-SY5Y neuroblastoma cells by protein kinase C activators and inhibitors. J Neurochem. 1992;58(4):1191-8. Epub 1992/04/01. PMID: 1548459.
31. Leli U, Shea TB, Cataldo A, Hauser G, Grynspan F, Beermann ML, et al. Differential expression and subcellular localization of protein kinase C alpha, beta, gamma, delta, and epsilon isoforms in SH-SY5Y neuroblastoma cells: modifications during differentiation. J Neurochem. 1993;60(1):289-98. Epub 1993/01/01. PMID: 8417148.
32. Baker M. Reproducibility crisis: Blame it on the antibodies. Nature. 2015;521(7552):274-6. Epub 2015/05/23. doi: 10.1038/521274a PMID: 25993940.
33. Bradbury A, Pluckthun A. Reproducibility: Standardize antibodies used in research. Nature. 2015;518(7537):27-9. Epub 2015/02/06. doi: 10.1038/518027a PMID: 25652980.
34. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 1978;38(11 Pt 1):3751-7. Epub 1978/11/01. PMID: 29704.